Australian Pharmacist

Pfizer’s Comirnaty COVID-19 vaccine has been provisionally approved by the Therapeutic Goods Administration (TGA) for use as a booster in those aged 16–17 years.

Four pharmacists were crowned the best of the west at PSA’s West Australian Annual Therapeutic Update (ATU) last weekend.

Doctor of clinical pharmacy, consultant pharmacist and pharmacovigilance expert Geraldine Moses discusses the scary adverse effects of CAM.

When under the care of a general practice pharmacist, patients recently discharged from hospital are far less likely to re-present, according to new research.

Changes to the Opioid Dependence Treatment program could make long-acting injectable buprenorphine the best option for many people.

Rather than managing adverse events after the fact, the ACTmed trial helps pharmacists tackle medicine-related problems before they arise.